## STE: STERIS plc - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.3% below STRENGTH zone (3.0-6.0%); PEG 1.73 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($245.33)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Congress Asset Management Co. Raises Stock Holdings in STERIS plc $STE**
- Source: MarketBeat | 20251222T090453 | Somewhat-Bullish | Relevance: 100%
- Congress Asset Management Co. has increased its stake in STERIS plc (NYSE:STE) by 8.4% in the third quarter, now owning 133,224 shares valued at $32.965 million. Other institutional investors have also adjusted their positions in the medical equipment provider. STERIS announced a quarterly dividend of $0.63 per share, with recent insider selling activity, while analysts maintain a "Moderate Buy" consensus rating with an average price target of $273.50.

**2. 18,834 Shares in STERIS plc $STE Bought by Addenda Capital Inc.**
- Source: MarketBeat | 20251220T020859 | Somewhat-Bullish | Relevance: 100%
- Addenda Capital Inc. recently acquired 18,834 shares of STERIS plc (NYSE:STE), valued at approximately $4.66 million, contributing to institutional and hedge fund ownership of 94.69% of the stock. STERIS reported strong Q3 earnings, exceeding estimates and setting optimistic FY2026 guidance, while analysts maintain a "Moderate Buy" rating with a target price of $273.50. Despite these positive indicators, corporate insiders have been net sellers, disposing of 25,203 shares over the past 90 days.

**3. STERIS plc $STE Shares Bought by Foster Victor Wealth Advisors LLC**
- Source: MarketBeat | 20251221T120121 | Bullish | Relevance: 100%
- Foster Victor Wealth Advisors LLC significantly increased its stake in STERIS plc (NYSE:STE), acquiring an additional 4,646 shares and bringing their total to 80,029 shares valued at $19.41 million. This makes STERIS the 21st largest holding in their portfolio, representing about 1.2% of their investments. The medical equipment provider also delivered strong Q3 results, beating analyst expectations with $2.47 EPS and $1.46 billion in revenue, and announced a quarterly dividend of $0.63 per share.

**4. IV Dressing Market Set for Dynamic Rise with Key Players Becton, Dickinson and Company, Lohmann & Rauscher, Komal Health Care Pvt. Ltd.**
- Source: openPR.com | 20251222T090902 | Somewhat-Bullish | Relevance: 60%
- The IV Dressing Market is projected to grow from USD 881.5 million in 2025 to USD 1,265.4 million by 2032, exhibiting a CAGR of 5.3%, driven by increasing industry demand and technological advancements. A new report by Coherent Market Insights details this growth, identifying key players like Becton, Dickinson and Company and 3M, and providing comprehensive analysis across product types, applications, end-users, and regions. The study offers actionable insights for strategic decision-making, covering market dynamics, competitive landscapes, and future opportunities.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 11 ($0.79M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+0.4%)
- Blackrock Inc.: 8.9% (+1.3%)
- Massachusetts Financ: 4.9% (-7.7%)
- State Street Corpora: 4.4% (+4.0%)
- Morgan Stanley: 4.3% (+8.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.73 elevated, pricing in significant growth expectations. Forward P/E 22.9x stretched relative to 9% growth. Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.48). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.1B |
| Beta | 1.01 |
| 52W Range | $200.98 - $268.60 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.73 |
| Forward P/E | 22.9 |
| Current P/E | 25.0 |
| YoY Growth | 9.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.3% (minimal 5-day change). Below STRENGTH zone by 3.3pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). MACD histogram bearish (-1.04), momentum weakening. RSI neutral at 49. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.30% (CS: 47) | Neutral |
| RSI_14 | 48.9 | Neutral |
| MACD Histogram | -1.04 | Bearish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 1.011x | Above |
| vs SMA200 | 1.065x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $255.09
- **Stop Loss:** $245.33 (3.8% risk)
- **Target:** $264.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 122
- **Position Value:** $31,120.98
- **Portfolio %:** 31.12%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-04 (Est: $2.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.35 | $2.47 | +5.1% |
| 2025Q2 | $2.26 | $2.34 | +3.4% |
| 2025Q1 | $2.60 | $2.74 | +5.4% |
| 2024Q4 | $2.32 | $2.32 | -0.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*